ArticleJOP : Journal of the pancreas2018

Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.

Brandon C Chapman et al.PubMed ↗Full text ↗

No numbers read from the abstract.